These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22844731)

  • 1. [The cognitive deficit in schizophrenia].
    Krivoy A; Fischel T; Weizman A
    Harefuah; 2012 May; 151(5):277-80, 319. PubMed ID: 22844731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cognitive dysfunction in schizophrenia.
    Peuskens J; Demily C; Thibaut F
    Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Memory disorders in schizophrenia].
    Danion JM; Peretti S; Gras-Vincendon A; Singer L
    Encephale; 1992; 18 Spec No 2():315-28. PubMed ID: 1363948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
    Kahn JP
    Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The fragmentation of representational space in schizophrenia].
    Plagnol A; Oïta M; Montreuil M; Granger B; Lubart T
    Encephale; 2003; 29(5):401-11. PubMed ID: 14615689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
    Carbon M; Correll CU
    CNS Spectr; 2014 Dec; 19 Suppl 1():38-52; quiz 35-7, 53. PubMed ID: 25403863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any impact of cognitive remediation on an ecological test in schizophrenia?
    Royer A; Grosselin A; Bellot C; Pellet J; Billard S; Lang F; Brouillet D; Massoubre C
    Cogn Neuropsychiatry; 2012; 17(1):19-35. PubMed ID: 21707472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of cognitive functioning in first episode schizophrenia spectrum disorders.
    Townsend LA; Norman RM
    Expert Rev Neurother; 2004 Jan; 4(1):61-8. PubMed ID: 15853616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of cognitive from affective components of theory of mind in schizophrenia.
    Shamay-Tsoory SG; Shur S; Barcai-Goodman L; Medlovich S; Harari H; Levkovitz Y
    Psychiatry Res; 2007 Jan; 149(1-3):11-23. PubMed ID: 17107716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive functioning component mechanisms and schizophrenia.
    Kerns JG; Nuechterlein KH; Braver TS; Barch DM
    Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
    Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
    Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioaffective factors modulate working memory in schizophrenia patients.
    Park S; Gibson C; McMichael T
    Neuroscience; 2006 Apr; 139(1):373-84. PubMed ID: 16337745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.